Approximately 64 million Americans suffer from cardiovascular complications, which are increasingly being observed in younger age groups, including adolescents. Consequently it is no surprise that consumers are becoming increasingly concerned about heart disease and its risk factors, including the role of high blood cholesterol levels, which cause about a third of all cases of all cardiovascular disease, resulting in nearly 17 million deaths annually. Such increased consumer awareness coupled with valid concerns about prescription drugs has driven demand for natural heart-health products. Cholesstrinol™ is a widely scoped and all-encompassing platform that provides numerous targeted and customized solutions for consumers with specific cardiovascular concerns.
Cholesstrinol™ is supported by a strong platform of clinical evidence demonstrating the conclusive ability to deliver a desirable range of heart-healthy benefits. These attributes may include significantly improving healthy total cholesterol and triglyceride levels, as well as healthy LDL, VLDL, and HDL cholesterol levels, providing powerful antioxidant effects, promoting the body’s natural inflammatory response, and supporting healthy blood pressure and glucose levels. In addition, Cholesstrinol™ helps regulate many of the key biomarkers associated with metabolic syndrome.
The benefits of the ingredients in the Cholesstrinol™ family of formulas have been validated in hundreds of clinical studies. The fact is, there are thousands of studies supporting the many health benefits of both marine Omega-3 EFAs and soy based plant sterol and sterol esters. Some products claim to be “clinically proven”; however, the ingredients used in the trial are not available to the consumer. Furthermore, too often the effective dose used in the clinical trials is not the same dosage found in supplements on retail shelves. SourceOne provides a consistent and reliable supply of the science-based ingredients that make up our Cholesstrinol™ family of formulas – the same ingredients at the same effective dose used in the clinical trials.
Also, Alternative Therapies in Health and Medicine, November/December, 2007, Vol. 13, No. 6, published the results of several studies that combined PMF-source® and TocoSource® palm tocotrienols branded Sytrinol® that was manufactured and distributed by SourceOne from 2003-2008. The largest study of the group, a 12-week double-blind, placebo-controlled protocol with 120 subjects, resulted in significant improvements in total cholesterol (-30%), LDL (-27%), and triglycerides (-34%), compared to placebo. In addition, HDL levels increased 4%, resulting in a significant 29% improvement in the LDL:HDL ratio.*
In the table below it is clear that patented Cholesstrinol at 300mg is 10X more potent than 90% concentrated Omega-3 fish oil in supporting Healthy Triglyceride Levels Naturally.
Cholesstrinol™ targets different mechanisms and bio-pathways to produce synergistic results for the body’s natural promotion of healthy total cholesterol, LDL cholesterol, and triglyceride levels. Additionally, Cholesstrinol™ is a powerful antioxidant with numerous heart health benefits that help maintain healthy inflammatory responses.
